Demo Data from EDBT 2026 / reviewers in the wild / expert
Monika Jelizarow
dblp:75/8321
· DBLP profile ↗
1ranked-venue papers
1as first author
0since 2021 · last 2010
—ORCID · none
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 1 · 1 first-author
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 100% |
Topics — the 2 heaviest of 2, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › biostatistics
statistical bioinformatics |
0.1 | 1 | 2010 | Over-optimism in bioinformatics: an illustration · Bioinform. 2010 |
Bioinformatics and computational biology › gene expression analysis
gene expression classification |
0.0 | 1 | 2010 | Over-optimism in bioinformatics: an illustration · Bioinform. 2010 |
Methods — techniques the papers use, named apart from their topics
shrinkage covariance estimation · 0.1linear discriminant analysis · 0.1cross-validation · 0.1
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2010 | Over-optimism in bioinformatics: an illustrationabstractMOTIVATION: In statistical bioinformatics research, different optimization mechanisms potentially lead to 'over-optimism' in published papers. So far, however, a systematic critical study concerning the various sources underlying this over-optimism is lacking. RESULTS: We present an empirical study on over-optimism using high-dimensional classification as example. Specifically, we consider a 'promising' new classification algorithm, namely linear discriminant analysis incorporating prior knowledge on gene functional groups through an appropriate shrinkage of the within-group covariance matrix. While this approach yields poor results in terms of error rate, we quantitatively demonstrate that it can artificially seem superior to existing approaches if we 'fish for significance'. The investigated sources of over-optimism include the optimization of datasets, of settings, of competing methods and, most importantly, of the method's characteristics. We conclude that, if the improvement of a quantitative criterion such as the error rate is the main contribution of a paper, the superiority of new algorithms should always be demonstrated on independent validation data. AVAILABILITY: The R codes and relevant data can be downloaded from http://www.ibe.med.uni-muenchen.de/organisation/mitarbeiter/020_professuren/boulesteix/overoptimism/, such that the study is completely reproducible. Monika Jelizarow, Vincent Guillemot, Arthur Tenenhaus, Korbinian Strimmer, Anne-Laure Boulesteix |
Bioinform. | 1 |